John E. Bailey, Jr. is listed as a director on 3 SEC Form D filings by 1 issuer between Sep 2019 and May 2022: Emergo Therapeutics, Inc. (Durham, NC — pharmaceuticals — 2019–2022; $12M reported sold to 110 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for John E. Bailey, Jr. and found 7 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "JOHN BAILEY" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.